Cargando…
WAF1/CIP1 structural abnormalities do not contribute to cell cycle deregulation in ovarian cancer.
Mutations in the WAF1/CIP1 gene were not found in 36 ovarian carcinomas, including tumours with loss of heterozygosity at the WAF1/CIP1 locus and/or lacking p53 mutations. In addition, no association was demonstrable between a polymorphism in a conserved region of the WAF1/CIP1 gene and ovarian carc...
Autores principales: | Wan, M., Cofer, K. F., Dubeau, L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074480/ https://www.ncbi.nlm.nih.gov/pubmed/8645586 |
Ejemplares similares
-
Cell Cycle‐dependent Modulation of Promoter Activities of RB and WAF1/Cip1 Genes
por: Matsumoto, Takuji, et al.
Publicado: (1998) -
The role of p21Waf1/CIP1 as a Cip/Kip type cell-cycle
regulator in oral squamous cell carcinoma (Review).
por: Pérez-Sayáns, Mario, et al.
Publicado: (2013) -
Overexpression of FOXG1 contributes to TGF-β resistance through inhibition of p21(WAF1/CIP1) expression in ovarian cancer
por: Chan, D W, et al.
Publicado: (2009) -
Epigenetic Regulation of p21(cip1/waf1) in Human Cancer
por: Ocker, Matthias, et al.
Publicado: (2019) -
Chloroquine reverses chemoresistance via upregulation of p21(WAF1/CIP1) and autophagy inhibition in ovarian cancer
por: Hwang, Jae Ryoung, et al.
Publicado: (2020)